BridgeMD
Compares treatment options for Metabolic Syndrome
Official title To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome
ClinicalTrials.gov ID: NCT06515652
What this study is testing
What is rosuvastatin, METFORMIN, Sitagliptin, Telmisartan, Cinnamon. garlic, Ginger, Methi dana, Arjun?
rosuvastatin, METFORMIN, Sitagliptin, Telmisartan, Cinnamon. garlic, Ginger, Methi dana, Arjun is an investigational medicine, being studied as a potential treatment for metabolic syndrome.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Metabolic syndrome is an important global public health problem and comprises a group of complex risk factors, including obesity, dyslipidemia, hyperglycemia, and hypertension. One of the main diagnostic components of metabolic syndrome is obesity, which is usually measured by the waist circumference and the intra-abdominal visceral fat, in addition to dyslipidemia (the condition of raised triglycerides and reduced high density lipoprotein (HDL)-cholesterol in blood; other components are raised blood pressure and fasting plasma glucose, all of which are related to weight gain.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 65
You may be able to join if
- Patients ageing between 35-65 years;
- Patients with a diagnosis of metabolic syndrome according to the criteria of IDF 2005
You likely can't join if
- Pregnant \& lactating female
- Use of insulin or sulfonamide derivative oral antidiabetic drugs
- Doing heavy physical activity or working in a physically demanding job
- Presence of liver or kidney disease, or immune deficiency
- Patients with history of myocardial infarction, coronary artery bypass surgery, unstable angina \& cardiac failure.
- Conditions that will seriously affect weight management such as having had bariatric surgery
See the full eligibility criteria
- Patients ageing between 35-65 years;
- Patients with a diagnosis of metabolic syndrome according to the criteria of IDF 2005
- Pregnant \& lactating female
- Use of insulin or sulfonamide derivative oral antidiabetic drugs
- Doing heavy physical activity or working in a physically demanding job
- Presence of liver or kidney disease, or immune deficiency
- Patients with history of myocardial infarction, coronary artery bypass surgery, unstable angina \& cardiac failure.
- Conditions that will seriously affect weight management such as having had bariatric surgery
- Determined to have had an unintentional sudden weight loss of more than 5% in the last three months
- Intellectual disability or significant medical or psychiatric illness as documented by the referring doctor.
- Any contraindication to the use of drugs involved in the study
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Sindh, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.